banner
CDK inhibitor Palbociclib, Purity ≥98%
Inquiry

Cat. No.: X24-05-ZQ767

CDK inhibitor Palbociclib, Purity ≥98%

Synonym: 571190-30-2; PD0332991; PD-0332991; PD 0332991; CDK inhibitor

  • CAS Number: 571190-30-2
  • Compound CID: 5330286
img
Product Size
10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Palbociclib is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D2, and DYRK1A.
Molecular Weight
447.53
Molecular Formula
C24H29N7O2
Targets
Cdk4/cyclin D1: 11 nM; Cdk4/cyclin D3: 9 nM; Cdk6/cyclin D2: 16 nM; DYRK1A: 2000 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Palbociclib (PD 0332991) can be used to study the selective inhibition of CDK4/6 in cancer therapy.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0